TATA CAPITAL LTD: ₹945.00 (0.00%)     TATA REFRACTORIES LTD - KROSAKI: ₹1795.00 (0.00%)     HERO FINCORP LTD: ₹1595.00 (0.00%)     SBI MUTUAL FUNDS LTD: ₹2750.00 (0.00%)     NATIONAL STOCK EXCHANGE: ₹2275.00 ▼ (-0.44%)     POLYMATECH ELECTRONICS LTD: ₹99.00 (0.00%)     HDFC SECURITIES LTD: ₹10750.00 (0.00%)     CHENNAI SUPER KINGS LTD: ₹192.00 (0.00%)     CAPGEMINI TECHNOLOGY SERVICES: ₹12250.00 (0.00%)     STERLITE GRID 5 UNLISTED SHARES: ₹348.00 (0.00%)     MOHAN MEAKIN LTD: ₹2300.00 (0.00%)     MANJUSHREE TECNHOPACK INDIA LTD: ₹925.00 (0.00%)     SPRAY ENGINEERING DEVICES LTD: ₹345.00 (0.00%)     DEEPAK HOUSEWARE AND TOYS: ₹72.00 (0.00%)     KURLON ENTERPRISE LIMITED: ₹450.00 (0.00%)     DELTA GALAXY ENGINEERING SERVICES: ₹56.00 (0.00%)     INDIAN POTASH LTD: ₹3450.00 (0.00%)     NCL BUILDTEK LTD: ₹245.00 (0.00%)     OYO HOTELS LTD: ₹43.00 (0.00%)     ORBIS FINANCIALS CORPORATION LTD: ₹545.00 (0.00%)     APOLLO GREEN ENERGY LTD: ₹192.00 ▼ (-1.03%)     OTIS ELEVATORS COMPANY INDIA LTD: ₹3900.00 (0.00%)     STERLITE POWER TRANSMISSION LTD: ₹575.00 (0.00%)     UTKARSH MICRO FINANCE LTD: ₹205.00 (0.00%)     MERINO LAMINATES LTD: ₹3250.00 (0.00%)     CARRIER AIRCONDITIONING & REFRIGERATION: ₹535.00 (0.00%)     GREENZO ENERGY INDIA LTD: ₹650.00 (0.00%)     VEEDA CHEMICAL RESEARCH LTD: ₹475.00 (0.00%)     METROPOLITAN STOCK EXCHANGE (MSEI): ₹8.25 (0.00%)     FLY SBS UNLISTED SHARES: ₹425.00 (0.00%)     VIKRAM SOLAR LTD: ₹368.00 ▼ (-1.87%)     STUDDS ACCESSORIES LTD: ₹650.00 (0.00%)     API HOLDINGS LTD: ₹7.90 (0.00%)     NCDEX: ₹285.00 (0.00%)     COCHIN INTERNATIONAL AIRPORT LTD: ₹495.00 ▲ (2.06%)     MATRIX GAS AND RENEWABLES LTD: ₹54.00 (0.00%)     GOODLUCK DEFENCE & AEROSPACE LTD: ₹335.00 (0.00%)     B9 BEVERAGES LTD: ₹345.00 (0.00%)     RRP S4E INNOVATIONS: ₹275.00 (0.00%)     DALMIA BHARAT REFRACTORIES LTD: ₹255.00 (0.00%)     IMAGINE MARKETING LTD: ₹1595.00 (0.00%)     CARE HEALTH LTD: ₹162.00 (0.00%)     LAVA INTERNATIONAL LTD: ₹42.00 (0.00%)     HINDUJA LEYLAND FINANCE LIMITED: ₹218.00 (0.00%)     NSDL: ₹1035.00 (0.00%)     PHILIPS LIGHTING SIGNIFY INNOVATIONS: ₹1275.00 (0.00%)     ASK INVESTMENT MANAGERS LIMITED: ₹1285.00 (0.00%)     STERLITE ELECTRIC LTD: ₹575.00 (0.00%)    

NCDEX

Price: ₹285.00

Last Entry Price: ₹285.00

Profit/Loss: ₹0.00 (0.00%)

Principles

Company Name

NCDEX


No. of Outstanding Shares

50676000


EPS

₹-5.47


Market Capitalization

₹1008.45 Crore


52 Week High

₹265.00


52 Week Low

₹198.00


DRHP Filed?

No


Sector

Finance Service

Script Name

NCDEX


PAN No.

AABCN7696K


PE ratio

None


Book value

₹90.65


Lifetime High

₹275.00 Sept. 17, 2021


Lifetime Low

₹198.00 Nov. 27, 2024


Available on

NSDL CDSL


CIN

U51909MH2003PLC140116

ISIN No.

INE127G01010


Face Value

₹ 10.00


P/S Ratio

7.42


P/BV

2.20


Day High

₹ 199.00


Day Low

₹ 199.00


ROFR Require

Yes


Registration Date

April 23, 2003

Stock Price Over Time

Share Details

NATIONAL COMMODITY & DERIVATIVES EXCHANGE LIMITED (NCDEX the Exchange) is a leading national-level, technology-driven de-mutualized online commodity exchange. NCDEX has a broad basket of permitted commodities aggregating to a total of 23 (which is also the highest). NCDEX includes commodities such as pulses, spices, and guar, which are not traded on any other platforms in the global scenario, and these commodities are also economically relevant to India, as they form an important component of India’s global trade. NCDEX became a deemed recognized stock exchange in September 2015. National Commodity & Derivatives Exchange Limited is regulated by the Securities and Exchange Board of India (SEBI). The main function of NCDEX is to serve as a platform for different types of investors for buying and selling commodities through fair price discovery. It also acquires and spreads the commodity news, in order, to help traders in making decisions. National Commodity & Derivatives Exchange Limited also helps in settling disputes between traders. As of 31st March 2020, NCDEX offered 21 commodities to trade with futures contracts and 5 agricultural commodities to trade with options contracts on its Exchange platform. It has a member base of 375 and its client base extends to 2.910 Million. Moreover, the company has more than 200 WRDA-approved warehouses. In FY 2020, NCDEX completely migrated to settlement via e-NWRs. National E-Repository Limited (NERL), a subsidiary of National Commodity & Derivatives Exchange Limited, has developed a network of 32 leading Banks, private, PSUs, and NBFCs acting as Pledgees, and issued around 1,17,317 eNWRs during FY 2020. Around 260 FPOs representing around 5,26,451 farmers from 13 states are connected with the NCDEX Exchange platform. In FY2020, National Commodity & Derivatives Exchange Limited filed a draft red herring prospectus with the Securities Exchange Board of India. It comprises a fresh issue of up to Rs. 100 Crores and an offer for sale of up to 14,453,774 Equity Shares by the selling shareholders.

National Commodity & Derivatives Exchange Limited Unlisted Shares - Company Overview

  • PharmEasy Industry Outlook According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025. Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products. Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%).
  • PharmEasy Industry Outlook According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025. Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products. Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%).

NCDEX Share Price.

NCDEX Outstanding Shares :
50676000
Face Value of NCDEX Share:
₹10.00 Per Equity Share
ISIN of NCDEX Share:
INE127G01010
Lot Size of NCDEX Shares:
300
PAN Number of NCDEX:
AABCN7696K
GST Number of NCDEX:
27AABCN7696K1ZR

NCDEX Incorporation Details

NCDEX CIN Number
U51909MH2003PLC140116
NCDEX Registration Date
April 23, 2003
Category / Sub-Category of NCDEX
COMMODITY AND ENERGY EXCHANGE
NCDEX Registered Office Address
First Floor, Akruti Corporate Park, Near G. E. Garden, L.B.S. Road, Kanjurmarg West, Mumbai 400 078.
NCDEX Registrar & Transfer Agent Address
Link Intime India Private Limited C 101, 247 Park, LBS Rd, Surya Nagar, Gandhi Nagar, Vikhroli West, Mumbai, Maharashtra 400083. Contact details: 022 - 4918 6270

NCDEX Board of Directors

Board Of Directors
Post
Mr. Aditya Puri
Chairman, Non-Executive Director
Mr. Deepak Vaidya
Independent ,non-executive Director
Mr. Ankur Thadani
Non-Executive Director
Mr. Ashutosh Sharma
Non-Executive Director
Ms. Vineeta Rai
Independent, Non-Executive Director
Dr. Jaydeep Tank
Independent, Non-Executive Director
Mr. Subramaniam Somasundaram
Independent, Non-Executive Director
Mr. Siddharth Shah
MD, and CEO
Mr. Harsh Parekh
Whole-time Director
Mr. Dharmil Sheth
Whole-time Director
Mr. Aditya Puri
Chairman, Non-Executive Director
Mr. Deepak Vaidya
Independent ,non-executive Director
Mr. Ankur Thadani
Non-Executive Director
Mr. Ashutosh Sharma
Non-Executive Director
Ms. Vineeta Rai
Independent, Non-Executive Director
Dr. Jaydeep Tank
Independent, Non-Executive Director
Mr. Subramaniam Somasundaram
Independent, Non-Executive Director
Mr. Siddharth Shah
MD, and CEO
Mr. Harsh Parekh
Whole-time Director
Mr. Dharmil Sheth
Whole-time Director

NCDEX Particulars of Subsidiary and Associate Companies

Company Name Relation Type %
Threpsi Solutions Private Limited Subsidiary 100.00
ARZT and Health Private Limited Subsidiary 100.00
Ascent Wellness and Pharma Solutions Private Limited Subsidiary 100.00
Docon Technologies Private Limited Subsidiary 100.00
Thyrocare Technologies Limited Subsidiary 71.18
AKP Healthcare Private Limited Subsidiary 51.00
Ayro Retail Solutions Private Limited Subsidiary 100.00
Venkatesh Medico Private Limited Subsidiary 51.00
Instinct Innovations Private Limited Subsidiary 100.00
Eastern Agencies Healthcare Private Limited Subsidiary 100.00
MARG ERP Ltd Associate 99.23
Equinox Labs Limited Associate 209.20
Impex Healthcare Private Limited Associate 90.30
Threpsi Solutions Private Limited Subsidiary 100.00
ARZT and Health Private Limited Subsidiary 100.00
Ascent Wellness and Pharma Solutions Private Limited Subsidiary 100.00
Docon Technologies Private Limited Subsidiary 100.00
Thyrocare Technologies Limited Subsidiary 71.18
AKP Healthcare Private Limited Subsidiary 51.00
Ayro Retail Solutions Private Limited Subsidiary 100.00
Venkatesh Medico Private Limited Subsidiary 51.00
Instinct Innovations Private Limited Subsidiary 100.00
Eastern Agencies Healthcare Private Limited Subsidiary 100.00
MARG ERP Ltd Associate 99.23
Equinox Labs Limited Associate 209.20
Impex Healthcare Private Limited Associate 90.30

FAQs for NCDEX

  • Q: Q.1 Does PharmEasy have an IPO?
    A: A.1 PharmEasy is preparing to launch its IPO.
  • Q: Q.2 How do I buy PharmEasy shares?
    A: A.2 One can buy PharmEasy shares online through our website, or investors can call us and confirm the deal with our Relationship Manager at 966999944, 7999252591, or 0731-4025544.
  • Q: Q.3 Is PharmEasy a profitable company?
    A: A.3 No, the company has not yet been profitable because PharmEasy suffered a loss of 39,924.96 million in FY 2022.
  • Q: Q.4 What is PharmEasy share price today?
    A: A.4 PharmEasy share price used to change every day like other companies ' share prices. To find out the most recent PharmEasy share price contact us
  • Q: Q5) Buying PharmEasy Pre IPO shares is legal in India or not ?
    A: Ans) Yes, Buying and Selling PharmEasy Pre IPO shares is absolutely 100 % legal in India, since the whole transaction process is regulated and governed by Securities and Exchange Board of India (SEBI).
  • Q: Q6) What is the duration of lock in period in the case of selling Pharmeasy Pre IPO Shares?
    A: Ans) In the case of selling , the duration of lock in period is 6 months from the date of listing of Pharmeasy IPO for retail investors
  • Q: Q7)What is the use of DIS in selling Pharmeasy Pre IPO Shares?
    A: Ans) The investors are required to fill the DIS (Delivery instruction slip) and submit to their broker. The mandatory fields in the DIS includes : a)ISIN no.of Pharmeasy Pre IPO Shares b)name of the pharmeasy Pre IPO Share c)total selling quantity of Pharmeasy Pre IPO shares d) DP ID and client ID e) off market annexure
  • Q: Q8) How to track news updates about Pharmeasy Pre IPO Shares?
    A: Ans) For tracking news updates about Pharmeasy Pre IPO shares you can simply visit our website news section https://wwipl.com/news to get the latest updates about Pharmeasy Pre IPO shares.
  • Q: Q9) How much time is required to credit the Pharmeasy Pre IPO Shares into the Demat Account?
    A: Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account. Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account. Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account.
  • Q: Q10) What is the minimum required amount for making investments in Pharmeasy Pre IPO shares?
    A: Ans) The minimum required amount for investing in Pharmeasy Pre IPO Shares is 10000 Rupees.
  • Q: Q.1 Does PharmEasy have an IPO?
    A: A.1 PharmEasy is preparing to launch its IPO.
  • Q: Q.2 How do I buy PharmEasy shares?
    A: A.2 One can buy PharmEasy shares online through our website, or investors can call us and confirm the deal with our Relationship Manager at 966999944, 7999252591, or 0731-4025544.
  • Q: Q.3 Is PharmEasy a profitable company?
    A: A.3 No, the company has not yet been profitable because PharmEasy suffered a loss of 39,924.96 million in FY 2022.
  • Q: Q.4 What is PharmEasy share price today?
    A: A.4 PharmEasy share price used to change every day like other companies ' share prices. To find out the most recent PharmEasy share price contact us
  • Q: Q5) Buying PharmEasy Pre IPO shares is legal in India or not ?
    A: Ans) Yes, Buying and Selling PharmEasy Pre IPO shares is absolutely 100 % legal in India, since the whole transaction process is regulated and governed by Securities and Exchange Board of India (SEBI).
  • Q: Q6) What is the duration of lock in period in the case of selling Pharmeasy Pre IPO Shares?
    A: Ans) In the case of selling , the duration of lock in period is 6 months from the date of listing of Pharmeasy IPO for retail investors
  • Q: Q7)What is the use of DIS in selling Pharmeasy Pre IPO Shares?
    A: Ans) The investors are required to fill the DIS (Delivery instruction slip) and submit to their broker. The mandatory fields in the DIS includes : a)ISIN no.of Pharmeasy Pre IPO Shares b)name of the pharmeasy Pre IPO Share c)total selling quantity of Pharmeasy Pre IPO shares d) DP ID and client ID e) off market annexure
  • Q: Q8) How to track news updates about Pharmeasy Pre IPO Shares?
    A: Ans) For tracking news updates about Pharmeasy Pre IPO shares you can simply visit our website news section https://wwipl.com/news to get the latest updates about Pharmeasy Pre IPO shares.
  • Q: Q9) How much time is required to credit the Pharmeasy Pre IPO Shares into the Demat Account?
    A: Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account. Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account. Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account.
  • Q: Q10) What is the minimum required amount for making investments in Pharmeasy Pre IPO shares?
    A: Ans) The minimum required amount for investing in Pharmeasy Pre IPO Shares is 10000 Rupees.